Skip to main navigation Skip to search Skip to main content

New frontiers in the management of dyslipidaemia: Proprotein convertase subtilisin/kexin 9 inhibitors and small interfering ribonucleic acid

Tim Tse*, Bosco Wu, Simon Willcock, Sanjyot Vagholkar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)413-416
Number of pages4
JournalAustralian Journal of General Practice
Volume52
Issue number6
DOIs
Publication statusPublished - Jun 2023

Cite this